drugset / Trial / NCT04372940
Tranexamic Acid in Gender Mastectomy
RandomizedSingle-groupDouble-blindSupportive care
Summary
The goal of this study is to examine the use of tranexamic acid (TXA) in gender mastectomy surgery, specifically looking at volume loss (blood and transudate) postoperatively.
Timeline
- Start
- 2023-01
- Primary completion
- 2024-01
- Completion
- 2024-01
Outcome
Outcome not reported
Stopped: “due to COVID”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 2.5 % | Topical |
Indications
No indication recorded.